Prothena(爱尔兰)

Prothena

Prothenawww.prothena.comProthenaCorporationplc(PRTA.US)总部位于爱尔兰都柏林，前身为「NeotopeCorporationLimited」，2012年10月更为现名，主要从事单克隆抗体药物的研发及生产，用于治疗帕金森氏症及转移性癌症等。ProthenaCorporationplcisaclinicalstagebiotechnologycomp anyfocusedonthediscovery,developmentandcommercializationofnovelantibodiesforthepotentialtreatmentofabroadrangeofdiseasesthatinvolveproteinmisfoldingandcelladhesion,particularlyonthediscovery,developmentandcommercializationofpotentialtherapeuticmonoclonalantibodiesdirectedspecificallytodisease-causingproteins.Thesepotentialtherapieshaveabroadrangeofindications,includingALandAAformsofamyloidosis(NEOD001),Parkinson’sdiseaseandrelatedsynucleinopathies(PRX002),andnovelcelladhesiontargetsinvolvedininflammatorydiseaseandmetastaticcancers(PRX003).Prothenaconductsitsoperationsthroughitswhollyownedsubsidiaries,NeotopeBiosciencesLimited,OnclaveTherapeuticLimite